First Trust NYSE Arca Biotechnology Index Fund
339 hedge funds and large institutions have $2.02B invested in First Trust NYSE Arca Biotechnology Index Fund in 2026 Q2 according to their latest regulatory filings, with 62 funds opening new positions, 80 increasing their positions, 102 reducing their positions, and 27 closing their positions.
239% more call options, than puts
Call options by funds: $6.05M | Put options by funds: $1.78M
130% more first-time investments, than exits
New positions opened: 62 | Existing positions closed: 27
22% more capital invested
Capital invested by funds: $1.65B → $2.02B (+$365M)
10% more funds holding
Funds holding: 309 → 339 (+30)
2.31% less ownership
Funds ownership: 72.91% → 70.61% (-2.3%)
22% less repeat investments, than reductions
Existing positions increased: 80 | Existing positions reduced: 102
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bessemer Group
Woodbridge,
New Jersey
|
+$29.7M |
| 2 |
Two Sigma Investments
New York
|
+$9.8M |
| 3 |
SF
Summit Financial
Parsippany,
New Jersey
|
+$9.01M |
| 4 |
Stifel Financial
St. Louis,
Missouri
|
+$4.79M |
| 5 |
Raymond James Financial
St Petersburg,
Florida
|
+$3.98M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
First Trust Advisors
Wheaton,
Illinois
|
-$27.2M |
| 2 |
3F
360 Financial
Wayzata,
Minnesota
|
-$15.7M |
| 3 |
Envestnet Asset Management
Chicago,
Illinois
|
-$13.9M |
| 4 |
LPL Financial
San Diego,
California
|
-$7.96M |
| 5 |
AssetMark Inc
Concord,
California
|
-$6.63M |
FBT Hedge Fund Activity: Q2 2026 in Review
339 of the 8,303 institutional investors tracked by Wall St. Rank reported a position in First Trust NYSE Arca Biotechnology Index Fund (FBT) for Q2 2026, worth a combined $2.02B — up 22% from $1.65B a quarter earlier.
Buyers outnumbered sellers: 62 funds opened new FBT positions and 27 closed out — a net gain of 35 holders — while 80 added to existing stakes and 102 trimmed.
The largest buyer was Bessemer Group, opening a new position worth an estimated $29.7M. The largest seller was First Trust Advisors, cutting an estimated $27.2M.
- 339 institutional investors held First Trust NYSE Arca Biotechnology Index Fund (FBT) as of Q2 2026, up from 309 in Q1 2026.
- Funds reported $2.02B of First Trust NYSE Arca Biotechnology Index Fund stock for Q2 2026, up 22% quarter-over-quarter.
- 62 funds opened new First Trust NYSE Arca Biotechnology Index Fund positions in Q2 2026 and 27 closed out, a net change of +35 holders.
- The largest First Trust NYSE Arca Biotechnology Index Fund buyer in Q2 2026 was Bessemer Group, an estimated $29.7M added.
- The largest First Trust NYSE Arca Biotechnology Index Fund seller in Q2 2026 was First Trust Advisors, an estimated $27.2M sold.
Based on aggregated 13F filings for Q2 2026.